ISAI, a French early stage and small cap private equity fund backed by a growing list of European - largely French entrepreneurs and high ranking senior executives - has re-invested in French travel agency-linked business, Evaneos. Fellow corporate venturing outfit, XAnge Private Equity, also participated in the $6m series B round. The company has raised $7m since it was established in 2009.

MemorialCare Innovation Fund, a strategic investment company wholly owned by the MemorialCare Health System, has participated in a series B round of funding for eye stent specialist Ivantis worth $46.5m.

Life sciences firm Promentis Pharmaceuticals raises $2.9m to develop drugs targeting schizophrenia and other central nervous system disorders.

IDG Ventures India has participated in a series B round funding in existing portfolio company Forus Health. The company has raised $13.2m to date.

Berlin-based restaurant booking platform raises $8 million series B led by Holtzbrinck and DN Capital with ambitions to broaden into a marketing and commerce platform for local businesses.

Chinese-US contract researcher joins $6.85m series B financing round for US biotechnology company Avelas Biosciences.

Amgen spin-off Atara Biotherapeutics raises $52m series B funding from investors including Amgen Ventures and Celgene Corporation, to accelerate clinical development of lead programs.

Japan's Ryoyo Electric Corporation joins Thomvest in series B funding for Tactus Technology, maker of dynamic surface technology that allows touchscreens to transform from being flat into a real, three-dimensional interface when needed.